The Organoid and Cell Culture Core
类器官和细胞培养核心
基本信息
- 批准号:10612964
- 负责人:
- 金额:$ 16.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-30 至 2027-03-31
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAdultBioinformaticsBiological ModelsCRISPR screenCRISPR/Cas technologyCatalogsCell CommunicationCell Culture SystemCell Culture TechniquesCell LineCellsChildhoodClinicalCoculture TechniquesCollaborationsCommunitiesConsultCryopreservationDataDevelopmentDigestive System DisordersDiseaseDisease modelDoctor of PhilosophyDrug ScreeningEducationEducational workshopEmerging TechnologiesEpithelial CellsEquipmentExperimental DesignsFeedbackGene ExpressionGenesGenomeGrantGrowthGuide RNAHepatobiliaryHomeostasisHumanHuman Cell LineHuman ResourcesInternetLaboratoriesLeadershipLentivirus VectorLibrariesLinkLiver diseasesLongevityMeasuresMediatingMedicineMissionModelingMolecularMorphologyMouse Cell LineMusMycoplasmaMycoplasma InfectionsOrganoidsPancreasPancreatic DiseasesPatientsProtocols documentationQuality ControlRNA InterferenceReagentReproducibilityResearchResearch PersonnelScienceScientistSeriesServicesStandardizationSurveysSystemTechniquesTechnologyTestingTissuesTrainingTraining and EducationTransgenic MiceTranslational ResearchTranslationsUniversitiesVisualizationWorkbioimagingcell repositorycost effectivecost effective measurescost effectivenessdrug testingexperimental studyexpression vectorgastrointestinalgenetically modified cellshigh resolution imaginginduced pluripotent stem cellmembernew technologynoveloperationpediatric patientspre-clinicalprogramsrepositorysingle cell analysistooltranscriptome sequencing
项目摘要
SUMMARY
The Organoid and Cell Culture Core (OCCC) will contribute to the mission of the Columbia University Digestive
and Liver Disease Research Center (CU-DLDRC) by serving members’ needs related to human and murine cell
culture systems for modeling of gastrointestinal, hepatobiliary and pancreatic diseases. These systems include
primary culture, genetically-engineered cell lines, spheroids and organoids as well as 3D co-culture. OCCC
platforms will benefit the majority of clinical and basic CU-DLDRC investigators, providing powerful tools to study
epithelial cells and their interactions in digestive homeostasis and disease, the central theme of the CU-DLDRC.
Directed by Drs. Hiroshi Nakagawa, MD, PhD and Kelley Yan, MD, PhD, two scientists with long-standing
complementary expertise in advanced cell culture and organoids, the OCCC will provide services, technologies,
quality control and cost-effectiveness to the CU-DLDRC investigators, including the Pilot and Feasibility grant
recipients. The OCCC will provide a rich repository of cell lines and human and mouse organoids that are well
annotated for identity, passage number, and Mycoplasma infection-free status, thereby providing quality control,
rigor and reproducibility. The OCCC will also assist CU-DLDRC investigators to generate 3D organoids from
their human and mouse tissues as well as from inducible pluripotent stem (iPS) cells, to analyze growth,
morphology, gene expression, and cell-cell interactions via co-culture experiments. The OCCC will integrate
advanced cell culture technologies for manipulating genome and gene expression via CRISPR/Cas9, RNA
interference, and inducible retroviral/lentiviral gene expression vectors in cell and organoid-based systems.
These approaches are further enhanced by coordinated multi-core workflows with the Clinical Biospecimen and
Research Core for patient- and disease-specific organoids; with the Bioinformatics and Single Cell Analysis Core
for the plate-RNAseq-based CRISPR and drug screens; and with the Bioimaging Core for functional visualization
of cells and organoids. The OCCC will promote the mission of the CU-DLDRC through the following interrelated
Specific Aims: To provide CU-DLDRC members and their laboratories with cell lines, advanced cell culture
platforms and technologies (Aim 1); to build and expand unique CU-DLDRC and national repositories of disease-
specific human and mouse 3D organoid libraries (Aim 2); and to enhance the technical capabilities of new and
established CU-DLDRC investigators through training on cell and organoid culture models and as well as
educational seminars on novel developments (Aim 3). The OCCC will be highly utilized with 71% of CU-DLDRC
members indicating use, most of them use of multiple OCCC services. In summary, the OCCC will provide highly
efficient and cost-effective services and unique models that do not currently exist in CU-DLDRC members’
laboratory and therefore constitute significant benefits. Through its services, OCCC will stimulate translational
science and collaborations in the CU-DLDRC and contribute to its mission to promote digestive disease science.
摘要
器官和细胞培养核心(OCCC)将为哥伦比亚大学消化中心的使命做出贡献
和肝病研究中心(CU-DLDRC),服务于成员与人和小鼠细胞相关的需求
用于胃肠道、肝胆和胰腺疾病建模的培养系统。这些系统包括
原代培养、基因工程细胞系、球体和有机体以及3D联合培养。OCCC
平台将使大多数临床和基础CU-DLDRC研究人员受益,为研究提供强大的工具
上皮细胞及其在消化稳态和疾病中的相互作用,这是CU-DLDRC的中心主题。
由中川浩博士和严凯利博士执导,这两位科学家长期从事
作为先进细胞培养和有机化合物方面的补充专业知识,OCCC将提供服务、技术、
CU-DLDRC调查员的质量控制和成本效益,包括试点和可行性补助金
收件人。OCCC将提供丰富的细胞系和人类和小鼠器官类物质
对身份、通道编号和支原体无感染状态进行注释,从而提供质量控制,
严密性和可重复性。OCCC还将协助CU-DLDRC调查人员从
他们的人类和小鼠组织以及可诱导的多能干细胞(IPS),以分析生长情况,
通过共培养实验的形态、基因表达和细胞与细胞的相互作用。OCCC将整合
通过CRISPR/Cas9、RNA调控基因组和基因表达的先进细胞培养技术
干扰和诱导逆转录病毒/慢病毒基因在细胞和有机物系统中的表达载体。
这些方法通过与临床生物医学和生物医学中心协调的多核心工作流程得到进一步增强
针对患者和疾病特定有机物的研究核心;具有生物信息学和单细胞分析核心
用于基于平板RNAseq的CRISPR和药物筛选;以及用于功能可视化的生物成像核心
细胞和细胞器。OCCC将通过以下相互关联的方式促进CU-DLDRC的使命
具体目标:为CU-DLDRC成员及其实验室提供细胞系、先进的细胞培养
平台和技术(目标1);建立和扩大独特的CU-DLDRC和国家疾病储存库--
特定的人和鼠3D有机类库(目标2);并加强新的和
通过细胞和有机物培养模型的培训建立了CU-DLDRC调查人员,以及
关于新发展的教育研讨会(目标3)。OCCC将得到高度利用,CU-DLDRC的利用率将达到71%
会员表示使用,其中大部分使用多项OCCC服务。总之,OCCC将提供高度的
高效、经济实惠的服务和独特的模式,这是CU-DLDRC成员目前不存在的
实验室,因此构成了重大的好处。通过其服务,OCCC将促进翻译
该中心致力于促进该中心的科学和合作,并为其促进消化疾病科学的使命作出贡献。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hiroshi Nakagawa其他文献
Hiroshi Nakagawa的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hiroshi Nakagawa', 18)}}的其他基金
Aldh2 and mitochondrial homeostasis in esophageal pathobiology
食管病理学中的 Aldh2 和线粒体稳态
- 批准号:
10159805 - 财政年份:2019
- 资助金额:
$ 16.83万 - 项目类别:
Aldh2 and mitochondrial homeostasis in esophageal pathobiology
食管病理学中的 Aldh2 和线粒体稳态
- 批准号:
9897450 - 财政年份:2019
- 资助金额:
$ 16.83万 - 项目类别:
Aldh2 and mitochondrial homeostasis in esophageal pathobiology
食管病理学中的 Aldh2 和线粒体稳态
- 批准号:
10383155 - 财政年份:2019
- 资助金额:
$ 16.83万 - 项目类别:
Autophagy and esophageal tissue remodeling in EoE
EoE 中的自噬和食管组织重塑
- 批准号:
10298488 - 财政年份:2017
- 资助金额:
$ 16.83万 - 项目类别:
Autophagy and esophageal tissue remodeling in EoE
EoE 中的自噬和食管组织重塑
- 批准号:
9367277 - 财政年份:2017
- 资助金额:
$ 16.83万 - 项目类别:
Autophagy and esophageal tissue remodeling in EoE
EoE 中的自噬和食管组织重塑
- 批准号:
10463814 - 财政年份:2017
- 资助金额:
$ 16.83万 - 项目类别:
Autophagy and esophageal tissue remodeling in EoE
EoE 中的自噬和食管组织重塑
- 批准号:
10615142 - 财政年份:2017
- 资助金额:
$ 16.83万 - 项目类别:
Integrative mouse pathobiology: GI epithelial biology and genetics
综合小鼠病理学:胃肠道上皮生物学和遗传学
- 批准号:
8690996 - 财政年份:2011
- 资助金额:
$ 16.83万 - 项目类别:
Integrative mouse pathobiology: GI epithelial biology and genetics
综合小鼠病理学:胃肠道上皮生物学和遗传学
- 批准号:
8226085 - 财政年份:2011
- 资助金额:
$ 16.83万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 16.83万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 16.83万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 16.83万 - 项目类别:
Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 16.83万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 16.83万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 16.83万 - 项目类别:
Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
- 批准号:
2230829 - 财政年份:2023
- 资助金额:
$ 16.83万 - 项目类别:
Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 16.83万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 16.83万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 16.83万 - 项目类别:
Grant-in-Aid for Scientific Research (C)